USP25 Elevates SHLD2‐Mediated DNA Double‐Strand Break Repair and Regulates Chemoresponse in Cancer
Advanced Science · 2024-07 · 11 (28)
DOI: 10.1002/advs.202403485 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 27.05.2024. Verfasst von Yunhui Li und 20 weiteren Autor:innen. Beteiligte Einrichtung: Medical Innovation Center, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, 200120, China. Hauptthemen laut MEDLINE: DNA Breaks, Double-Stranded, Ubiquitin Thiolesterase. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Plan, National Natural Science Foundation of China, Science and Technology Commission of Shanghai Municipality.
Abstract (Originalsprache)
DNA damage plays a significant role in the tumorigenesis and progression of the disease. Abnormal DNA repair affects the therapy and prognosis of cancer. In this study, it is demonstrated that the deubiquitinase USP25 promotes non‐homologous end joining (NHEJ), which in turn contributes to chemoresistance in cancer. It is shown that USP25 deubiquitinates SHLD2 at the K64 site, which enhances its binding with REV7 and promotes NHEJ. Furthermore, USP25 deficiency impairs NHEJ‐mediated DNA repair and reduces class switch recombination (CSR) in USP25 ‐deficient mice. USP25 is overexpressed in a subset of colon cancers. Depletion of USP25 sensitizes colon cancer cells to IR, 5‐Fu, and cisplatin. TRIM25 is also identified, an E3 ligase, as the enzyme responsible for degrading USP25. Downregulation of TRIM25 leads to an increase in USP25 levels, which in turn induces chemoresistance in colon cancer cells. Finally, a peptide that disrupts the USP25‐SHLD2 interaction is successfully identified, impairing NHEJ and increasing sensitivity to chemotherapy in PDX model. Overall, these findings reveal USP25 as a critical effector of SHLD2 in regulating the NHEJ repair pathway and suggest its potential as a therapeutic target for cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Innovation Center, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, 200120, China.
- Cancer Center, Tongji University School of Medicine, Shanghai, 200331, China.
- Department of Biochemistry and Molecular Biology, Tongji University School of Medicine, Shanghai, 200331, China.
- College of Biology, Hunan University, Changsha, 410082, China.
- Department of General Surgery and Colorectal Surgery, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, China.
- Translational Research Institute of Brain and Brain-Like Intelligence, Shanghai Fourth People's Hospital, School of Medicine, Tongji University, Shanghai, 200080, China.
ORCID-Profile: Jian Yuan
Förderung
- National Key Research and Development Plan
- National Natural Science Foundation of China
- Science and Technology Commission of Shanghai Municipality
- Fundamental Research Funds for the Central Universities
- Shanghai Municipal Health Bureau
Zitieren
APA
Li, Y., Li, L., Wang, X., Zhao, F., Yang, Y., Zhou, Y., Zhang, J., Wang, L., Jiang, Z., Zhang, Y., Chen, Y., Wu, C., Li, K., Zhang, T., Wang, P., Mao, Z., Zhu, W., Xu, X., Liang, S., …, & Yuan, J. (2024). USP25 Elevates SHLD2‐Mediated DNA Double‐Strand Break Repair and Regulates Chemoresponse in Cancer. Advanced Science, 11(28). https://doi.org/10.1002/advs.202403485
Vancouver
Li Y, Li L, Wang X, Zhao F, Yang Y, Zhou Y, et al. USP25 Elevates SHLD2‐Mediated DNA Double‐Strand Break Repair and Regulates Chemoresponse in Cancer. Advanced Science. 2024;11(28). doi:10.1002/advs.202403485
BibTeX
@article{Li2024,
author = {Li, Yunhui and Li, Lei and Wang, Xinshu and Zhao, Fei and Yang, Yuntong and Zhou, Yujuan and Zhang, Jiyuan and Wang, Li and Jiang, Zeshan and Zhang, Yuanyuan and Chen, Yuping and Wu, Chenming and Li, Ke and Zhang, Tingting and Wang, Ping and Mao, Zhiyong and Zhu, Weiguo and Xu, Xingzhi and Liang, Shikang and Lou, Zhenkun and Yuan, Jian},
title = {USP25 Elevates SHLD2‐Mediated DNA Double‐Strand Break Repair and Regulates Chemoresponse in Cancer},
journal = {Advanced Science},
year = {2024},
volume = {11},
number = {28},
doi = {10.1002/advs.202403485}
}
EUVIMED